Evidence map›Paper›PMID 24959850›Full record

ArticlePloS one2014

Chimeric Avidin--NMR structure and dynamics of a 56 kDa homotetrameric thermostable protein.

Helena Tossavainen, Sampo Kukkurainen, Juha A E Määttä, Niklas Kähkönen, Tero Pihlajamaa, Vesa P Hytönen, Markku S Kulomaa, Perttu Permi

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Helena TossavainenProgram in Structural Biology and Biophysics, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Sampo KukkurainenInstitute of Biomedical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland; Fimlab Laboratories, Tampere, Finland.
Juha A E MäättäInstitute of Biomedical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland; BioMediTech, Tampere, Finland; Fimlab Laboratories, Tampere, Finland.
Niklas KähkönenInstitute of Biomedical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland; BioMediTech, Tampere, Finland.
Tero PihlajamaaProgram in Structural Biology and Biophysics, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Vesa P HytönenInstitute of Biomedical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland; BioMediTech, Tampere, Finland; Fimlab Laboratories, Tampere, Finland.
Markku S KulomaaInstitute of Biomedical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland; BioMediTech, Tampere, Finland.
Perttu PermiProgram in Structural Biology and Biophysics, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chimeric avidin (ChiAVD) is a product of rational protein engineering remarkably resistant to heat and harsh conditions. In quest of the fundamentals behind factors affecting stability we have elucidated the solution NMR spectroscopic structure of the biotin-bound form of ChiAVD and characterized the protein dynamics through 15N relaxation and hydrogen/deuterium (H/D) exchange of this and the biotin-free form. To surmount the challenges arising from the very large size of the protein for NMR spectroscopy, we took advantage of its high thermostability. Conventional triple resonance experiments for fully protonated proteins combined with methyl-detection optimized experiments acquired at 58°C were adequate for the structure determination of this 56 kDa protein. The model-free parameters derived from the 15N relaxation data reveal a remarkably rigid protein at 58°C in both the biotin-bound and the free forms. The H/D exchange experiments indicate a notable increase in hydrogen protection upon biotin binding.

Indexed as

AvidinBiotinModels, MolecularMolecular WeightMutationNuclear Magnetic Resonance, BiomolecularProtein BindingProtein ConformationProtein EngineeringProtein MultimerizationThermodynamicsAvidinBiotin

Identifiers

PMID24959850
PMCPMC4069078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.